These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30876928)
1. Changes in Immunosuppressive Treatment of Chronic Graft-versus-Host Disease: Comparison of 2 Surveys within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and Switzerland. Wolff D; Hilgendorf I; Wagner-Drouet E; Jedlickova Z; Ayuk F; Zeiser R; Schäfer-Eckart K; Gerbitz A; Stadler M; Klein S; Middeke JM; Lawitschka A; Winkler J; Halter J; Holler E; Kobbe G; Stelljes M; Ditschkowski M; Greinix H Biol Blood Marrow Transplant; 2019 Jul; 25(7):1450-1455. PubMed ID: 30876928 [TBL] [Abstract][Full Text] [Related]
2. Diagnosis and treatment of ocular chronic graft-versus-host disease: report from the German-Austrian-Swiss Consensus Conference on Clinical Practice in chronic GVHD. Dietrich-Ntoukas T; Cursiefen C; Westekemper H; Eberwein P; Reinhard T; Bertz H; Nepp J; Lawitschka A; Heiligenhaus A; Seitz B; Messmer EM; Meyer-ter-Vehn T; Basara N; Greinix H; Datiles MB; Lee SJ; Pavletic SZ; Wolff D Cornea; 2012 Mar; 31(3):299-310. PubMed ID: 22157574 [TBL] [Abstract][Full Text] [Related]
3. German-Austrian-Swiss Consensus Conference on clinical practice in chronic graft-versus-host disease (GVHD): guidance for supportive therapy of chronic cutaneous and musculoskeletal GVHD. Marks C; Stadler M; Häusermann P; Wolff D; Buchholz S; Stary G; Lee S; Lawitschka A; Bertz H Br J Dermatol; 2011 Jul; 165(1):18-29. PubMed ID: 21466534 [TBL] [Abstract][Full Text] [Related]
4. Current practice in nutrition after allogeneic hematopoietic stem cell transplantation - Results from a survey among hematopoietic stem cell transplant centers. Toenges R; Greinix H; Lawitschka A; Halter J; Baumgartner A; Simon A; Arends J; Jäger P; Middeke M; Hilgendorf I; Klein S; Wagner-Drouet EM; Schmid C; Bug G; Wolff D; Clin Nutr; 2021 Apr; 40(4):1571-1577. PubMed ID: 33744601 [TBL] [Abstract][Full Text] [Related]
5. Current practice in diagnosis and treatment of acute graft-versus-host disease: results from a survey among German-Austrian-Swiss hematopoietic stem cell transplant centers. Wolff D; Ayuk F; Elmaagacli A; Bertz H; Lawitschka A; Schleuning M; Meyer RG; Gerbitz A; Hilgendorf I; Hildebrandt GC; Edinger M; Klein S; Halter J; Mousset S; Holler E; Greinix HT Biol Blood Marrow Transplant; 2013 May; 19(5):767-76. PubMed ID: 23376495 [TBL] [Abstract][Full Text] [Related]
6. Verification of the new grading scale for ocular chronic graft-versus-host disease developed by the German-Austrian-Swiss consensus conference on chronic GVHD. Blecha C; Wolff D; Holler B; Holler E; Weber D; Vogt R; Helbig H; Dietrich-Ntoukas T Ann Hematol; 2016 Feb; 95(3):493-9. PubMed ID: 26659079 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and staging of chronic graft-versus-host disease in the clinical practice. Greinix HT; Loddenkemper C; Pavletic SZ; Holler E; Socié G; Lawitschka A; Halter J; Wolff D Biol Blood Marrow Transplant; 2011 Feb; 17(2):167-75. PubMed ID: 20691801 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of ruxolitinib in the treatment of chronic graft-versus-host disease: a retrospective analysis. Denk A; Mittermaier C; Weber D; Fante M; Güneş S; Edinger M; Herr W; Wolff D Ann Hematol; 2024 Sep; 103(9):3755-3764. PubMed ID: 38916742 [TBL] [Abstract][Full Text] [Related]
9. The treatment of chronic graft-versus-host disease: consensus recommendations of experts from Germany, Austria, and Switzerland. Wolff D; Bertz H; Greinix H; Lawitschka A; Halter J; Holler E Dtsch Arztebl Int; 2011 Oct; 108(43):732-40. PubMed ID: 22114649 [TBL] [Abstract][Full Text] [Related]
10. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey. Zeiser R; Burchert A; Lengerke C; Verbeek M; Maas-Bauer K; Metzelder SK; Spoerl S; Ditschkowski M; Ecsedi M; Sockel K; Ayuk F; Ajib S; de Fontbrune FS; Na IK; Penter L; Holtick U; Wolf D; Schuler E; Meyer E; Apostolova P; Bertz H; Marks R; Lübbert M; Wäsch R; Scheid C; Stölzel F; Ordemann R; Bug G; Kobbe G; Negrin R; Brune M; Spyridonidis A; Schmitt-Gräff A; van der Velden W; Huls G; Mielke S; Grigoleit GU; Kuball J; Flynn R; Ihorst G; Du J; Blazar BR; Arnold R; Kröger N; Passweg J; Halter J; Socié G; Beelen D; Peschel C; Neubauer A; Finke J; Duyster J; von Bubnoff N Leukemia; 2015 Oct; 29(10):2062-8. PubMed ID: 26228813 [TBL] [Abstract][Full Text] [Related]
12. Navigating the Complexity of Chronic Graft-vs-Host Disease: Canadian Insights into Real-World Treatment Sequencing. Kim D; Taparia M; Robinson E; Mcgee M; Merali T Transplant Proc; 2024 Mar; 56(2):409-415. PubMed ID: 38342748 [TBL] [Abstract][Full Text] [Related]
13. Novel Approaches to the Treatment of Chronic Graft-Versus-Host Disease. Zeiser R J Clin Oncol; 2023 Apr; 41(10):1820-1824. PubMed ID: 36800551 [No Abstract] [Full Text] [Related]
14. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Vogl UM; Nagayama K; Bojic M; Hoda MA; Klepetko W; Jaksch P; Dekan S; Siersch V; Mitterbauer M; Schellongowski P; Greinix HT; Petkov V; Schulenburg A; Kalhs P; Rabitsch W Transplantation; 2013 Feb; 95(4):623-8. PubMed ID: 23274967 [TBL] [Abstract][Full Text] [Related]
15. Effect of Ruxolitinib on Lung Function after Allogeneic Stem Cell Transplantation. Bondeelle L; Chevret S; Hurabielle C; Samy L; Goletto T; Costantini A; Sicre de Fontbrune F; Michonneau D; Socié G; Tazi A; Bouaziz JD; Bergeron A Biol Blood Marrow Transplant; 2020 Nov; 26(11):2115-2120. PubMed ID: 32738501 [TBL] [Abstract][Full Text] [Related]
16. Review of Genetic Variation as a Predictive Biomarker for Chronic Graft-Versus-Host-Disease After Allogeneic Stem Cell Transplantation. Partanen J; Hyvärinen K; Bickeböller H; Bogunia-Kubik K; Crossland RE; Ivanova M; Perutelli F; Dressel R Front Immunol; 2020; 11():575492. PubMed ID: 33193367 [TBL] [Abstract][Full Text] [Related]
17. IL6-receptor antibody tocilizumab as salvage therapy in severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Kattner AS; Holler E; Holler B; Klobuch S; Weber D; Martinovic D; Edinger M; Herr W; Wolff D Ann Hematol; 2020 Apr; 99(4):847-853. PubMed ID: 32086584 [TBL] [Abstract][Full Text] [Related]
18. Effect of ruxolitinib on the oral mucosa of patients with steroid-refractory chronic Graft-versus-Host disease and oral involvement. Kaurinovic M; Delli K; Jonk AE; Biswana A; Hazenberg CLE; Choi G; de Groot MR; Morsink LM; Vissink A; Bellido M Clin Oral Investig; 2022 May; 26(5):4209-4216. PubMed ID: 35169886 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of BTK and ITK with Ibrutinib Is Effective in the Prevention of Chronic Graft-versus-Host Disease in Mice. Schutt SD; Fu J; Nguyen H; Bastian D; Heinrichs J; Wu Y; Liu C; McDonald DG; Pidala J; Yu XZ PLoS One; 2015; 10(9):e0137641. PubMed ID: 26348529 [TBL] [Abstract][Full Text] [Related]
20. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft- Bos S; Murray J; Marchetti M; Cheng GS; Bergeron A; Wolff D; Sander C; Sharma A; Badawy SM; Peric Z; Piekarska A; Pidala J; Raj K; Penack O; Kulkarni S; Beestrum M; Linke A; Rutter M; Coleman C; Tonia T; Schoemans H; Stolz D; Vos R Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38485149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]